Insmed Inc. buy Royal Bank of Canada
Start price
11.06.25
/
50%
€86.50
Target price
11.06.26
€92.91
Performance (%)
28.32%
Price
07:38
?
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 28.32%. This prediction currently runs until 11.06.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 17.647% | 17.647% |
| iShares Core DAX® | 0.648% | -0.148% |
| iShares Nasdaq 100 | -0.034% | 1.859% |
| iShares Nikkei 225® | 2.445% | 8.129% |
| iShares S&P 500 | 0.492% | 1.525% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Royal Bank of Canada from $99.00 to $106.00. They now have an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat